ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
7 hedge funds and large institutions have $995K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
$411K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
$32K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
$24K |
| 4 |
Morgan Stanley
New York
|
$16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
$35K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$208K |
| 2 |
VF
Virtu Financial
New York
|
$269K |
| 3 |
CG
Cutler Group
San Francisco,
California
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $411K | +$411K | +19,668 | New |
|
|
VF
2
Virtu Financial
New York
| $269K | -$11.8K | -561 | -4% |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $208K | -$100K | -4,779 | -32% |
|
|
4
UBS Group
Zurich,
Switzerland
| $35K | +$10.4K | +493 | +42% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $32K | +$32K | +1,535 | New |
|
|
6
Simplex Trading
Chicago,
Illinois
| $24K | +$24K | +1,169 | New |
|
|
7
Morgan Stanley
New York
| $16K | +$12.6K | +621 | +370% |
|
|
CG
8
Cutler Group
San Francisco,
California
| – | -$9K | -400 | Closed |
|